ArticleAnalytical chemistry2025
OpenDMS: An Open-Source Approach to Differential Mobility Spectrometry.
Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026Review
- Optically isolated High-Speed data acquisition system for ion mobility spectrometry.HardwareX · 2026Article
- A silicon microneedle array atmospheric pressure plasma ionization source for real-time trace gas chemical analysis.Microsystems & nanoengineering · 2026Article
- Differentiating superficial fungal infection from eczema using a heated dynamic-headspace skin VOC sampler: a hypothesis.Frontiers in medicine · 2026Article
- Development and Modification of Ion Mobility Mass Spectrometry Instrumentation for Enhanced Analysis of Biological Molecules.Journal of the American Society for Mass Spectrometry · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Differential mobility spectrometry (DMS) is a powerful gas-phase chemical analysis technique that separates ions based on their differential mobility in an asymmetric electric field, offering high sensitivity and rapid analysis crucial for fields such as proteomics, metabolomics, and environmental monitoring. Despite its advantages, the widespread adoption of DMS technology has been hindered by the high cost, proprietary nature, and lack of flexibility of commercial systems. In this study, we introduce OpenDMS, an open-source differential mobility spectrometry system designed to be accessible, customizable, and cost-effective. OpenDMS is constructed using readily available components with fully documented designs and open-source software for data processing and visualization. We demonstrate the system's performance through detailed dispersion plots and sensitivity analyses, achieving a theoretical limit of detection of 38 ppt and a resolving power of 1.57 at 10 ppb and 836 SV for an ethylbenzene monomer. The ability to interchange ionization sources, such as plasma and UV ionization, highlights the system's versatility. Importantly, we demonstrate that doping is compatible with the OpenDMS with the use of acetone shifting the DMMP monomer peak. By providing an open-source platform, OpenDMS aims to provide a solid foundation for access to DMS technology, fostering innovation and collaboration within the scientific community and accelerating advancements in various scientific fields.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.